MedTrace Logo

Preoperative Corticosteroids in Autoimmune Thyroid Disease

NCT05435547 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2025-05-01

No results posted yet for this study

Summary

This study proposes to randomize patients about to undergo surgery for their autoimmune, inflammatory thyroid disease, and determine if a short course of corticosteroids decreases the inflammation of the gland and makes surgery less difficult.

Conditions

  • Graves Disease
  • Hashimoto Disease

Interventions

DRUG

Dexamethasone

Will take Dexamethasone pre-operatively

DRUG

Placebo

Will take Placebo pre-operatively

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Alexandria McDow, MD · Indiana University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-16
Primary Completion
2026-06-30
Completion
2026-12-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05435547 on ClinicalTrials.gov